Navigation Links
"Regenovo" Cell 3D Printer Showing at 2014 CES
Date:1/6/2014

LAS VEGAS, Jan. 6, 2014 /PRNewswire/ -- Rather than building up layers of plastic, the bio-printer known as "Regenovo" uses biological material and living cells in the same layering process to create living tissue.

(Photo: http://photos.prnewswire.com/prnh/20140106/CN40577 )

The Regenovo can put different cells and materials into designated places to form complex 3D models. The designed architecture facilitates cell growth, organization and differentiation.

Regenovo's advantages are as follows:

  • It can print high viscosity materials
  • Cell damage rate in the printing process is low
  • The system is suitable for assembling under sterile condition

They said artificial human body parts can be printed for transplant and their next goal is to print artificial livers and kidneys for transplant in about 15 to 20 years.

Regenovo Biotechnology Co., Ltd. is a high-tech enterprises that provides professional integrated solutions in 3D printing technology for biomedical applications.

3D printing biological material is fast becoming an important industry for countries. The ability to recreate muscles, tendons and organs could change the world significantly.

www.regenovo.com

Media contact:

Dr. Xu Mingen, Ph.D.
Tel: +86 13819195776
consult@regenovo.com


'/>"/>
SOURCE Regenovo Biotechnology Co. Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Team U.S.A. Amputee Sprinter Wins 100 Meter Paralympic Silver Medal
2. OKI Europe Launches Cost-effective DICOM-embedded LED Printer Range - a First for Medical Imaging and Printing
3. Ricoh unveils MFPs and printers engineered for healthcare
4. Direct-to-Slide Printer Now Offers High-Performance Ink Ribbons
5. Researchers Use CT and 3-D Printers to Recreate Dinosaur Fossils
6. MEI Pharma Reports New Data Showing High Response Rates in Clinical Trial of Pracinostat and Azacitidine in Myelodysplastic Syndrome
7. Omthera Pharmaceuticals Presents Data From Analysis Of EVOLVE Trial Showing That Epanova Lowers ApoC-III, A Key Predictor of Cardiovascular Risk
8. Gynecologic Oncology Publishes New Clinical Study Showing Positive Performance of OVA1, Vermillions Ovarian Cancer Test
9. Virile Numbers Showing up in the Global Male Grooming Products Market, sees Kline
10. Isis Pharmaceuticals Reports Clinical Data Showing Blunting of Severe Increases in CRP Following Endotoxin Challenge With ISIS-CRP Rx
11. Isis Reports Phase 2 Data on ISIS-APOCIII Rx Showing Significant Reductions in Triglycerides and APOC-III in Patients with High Triglycerides and Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... West Pharmaceutical Services, Inc. (NYSE: ... drug administration, today announced that it will release third-quarter ... October 26, 2017, and will follow with a conference ... 9:00 a.m. Eastern Time. To participate on the call, ... ID is 94093362. ...
(Date:10/10/2017)... Oct. 10, 2017  NDS received FDA 510(k) clearance in May ... battery-powered display stand specifically designed for endoscopy environments. An innovative secondary ... a clinical solution to support the improvement of patient outcomes, procedural ... ... ...
(Date:10/4/2017)... Mass. , Oct. 4, 2017  According to the Centers for ... the end of October . PhysicianOne Urgent Care is helping communities across ... Westchester, NY , by offering no-cost* flu shots through the ... as mandated by certain health insurance regulations. ... The best time to get a flu shot is by the ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health & Wellness ... Moonlight to raise money for the American Heart Association Heart Walk. Teams of up ... work together to keep their treadmills moving for 5 hours. Treadmills will start at ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief ... advancements to physician colleagues, skilled nursing facility medical directors and other clinicians at ... of Wound Care." , "At many of these conferences we get to educate ...
Breaking Medicine News(10 mins):